The ROCKET AF Clinical Trial Executive Committee announced its secondary analysis of the phase III trial (ROCKET AF) of the oral anticoagulant rivaroxaban. The analysis was prompted by a December 2014 U.S. Food and Drug Administration (FDA) recall of a device used in the study.

ArtVentive Medical Group conducted its first animal study of its next generation of the ArtVentive Endoluminal Occlusion System (EOS Gen II). The EOS is designed for use in the peripheral vasculature and offers immediate and permanent vessel occlusion in arterial and venous settings.

Patients with in-hospital cardiac arrest (IHCA) have low survival rates—but why do some hospitals achieve higher survival than others?

Scientists at CBSET have presented preclinical evidence that the Manta Large Bore Vascular Closure Device (VCD) from Essential Medical successfully closed large bore arterial access without complication.

At the Radiological Society of North America (RSNA) 2015 annual meeting, GE Healthcare unveiled its new Logiq E9 ultrasound system.

The Revolution CT, Revolution HD and Revolution EVO CT scanners are now offered with a wider range of capabilities to enable clinicians to have more options in tailored computed tomography (CT) solutions specifically designed to their needs.

Precision Image Analysis Inc. (PIA) announced a dramatic expansion of its capabilities as a provider of medical imaging services. Building on its ISO-9001:2008 certification for its Quality Management System, PIA has adopted and implemented comprehensive Core Lab protocols and procedures.

Subscribe Now